Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans

Abstract Introduction One‐third of Medicare beneficiaries are enrolled in Medicare Advantage (MA). Yet, little is known about MA beneficiaries diagnosed with Alzheimer's disease (AD) and AD‐related dementias (AD/ADRD). Methods We calculated the prevalence of AD/ADRD diagnoses in 2014 and 2016 i...

Full description

Bibliographic Details
Main Authors: Eric Jutkowitz, Julie P.W. Bynum, Susan L. Mitchell, Noelle M. Cocoros, Oren Shapira, Kevin Haynes, Vinit P. Nair, Cheryl N. McMahill‐Walraven, Richard Platt, Ellen P. McCarthy
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Online Access:https://doi.org/10.1002/dad2.12048
id doaj-1548c96c22824f1caa0c0657b7815845
record_format Article
spelling doaj-1548c96c22824f1caa0c0657b78158452021-04-15T14:35:47ZengWileyAlzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring2352-87292020-01-01121n/an/a10.1002/dad2.12048Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plansEric Jutkowitz0Julie P.W. Bynum1Susan L. Mitchell2Noelle M. Cocoros3Oren Shapira4Kevin Haynes5Vinit P. Nair6Cheryl N. McMahill‐Walraven7Richard Platt8Ellen P. McCarthy9Department of Health Services Policy & Practice Brown University School of Public Health Providence Rhode Island 02912 USADepartment of Internal Medicine University of Michigan Ann Arbor Michigan USAHebrew Senior Life Hinda and Arthur Marcus Institute for Aging Research Boston Massachusetts USADepartment of Population Medicine Harvard Pilgrim Health Care Institute Boston Massachusetts USADepartment of Population Medicine Harvard Pilgrim Health Care Institute Boston Massachusetts USADepartment of Scientific Affairs Health Core, Inc. Wilmington Delaware USAHumana Healthcare Research Humana Inc. Louisville Kentucky USAHealthagen LLC part of the CVS Health family of companies Blue Bell Pennsylvania USADepartment of Population Medicine Harvard Pilgrim Health Care Institute Boston Massachusetts USAHebrew Senior Life Hinda and Arthur Marcus Institute for Aging Research Boston Massachusetts USAAbstract Introduction One‐third of Medicare beneficiaries are enrolled in Medicare Advantage (MA). Yet, little is known about MA beneficiaries diagnosed with Alzheimer's disease (AD) and AD‐related dementias (AD/ADRD). Methods We calculated the prevalence of AD/ADRD diagnoses in 2014 and 2016 in three MA plans. We determined the demographic characteristics of beneficiaries diagnosed with AD/ADRD, and whether they disenrolled from the MA plan for any reason within 364 days from the index date. Results In 2014 and 2016, the overall prevalence of AD/ADRD diagnoses was 5.6% and 6.5%, respectively. In 2016, AD/ADRD beneficiaries were on average 82.4 (SD = 7.4) years of age, 61.8% female, and had multiple comorbidities. By 364 days post‐index date, 32% of beneficiaries with AD/ADRD had disenrolled from their plan. The demographic characteristics of 2014 beneficiaries with diagnosed AD/ADRD were similar to their 2016 counterparts. Discussion The prevalence of AD/ADRD diagnosis in MA is lower than rates reported in Medicare fee‐for‐service.https://doi.org/10.1002/dad2.12048MedicareMedicare Advantagedementia, Alzheimer's diseasemild cognitive impairment
collection DOAJ
language English
format Article
sources DOAJ
author Eric Jutkowitz
Julie P.W. Bynum
Susan L. Mitchell
Noelle M. Cocoros
Oren Shapira
Kevin Haynes
Vinit P. Nair
Cheryl N. McMahill‐Walraven
Richard Platt
Ellen P. McCarthy
spellingShingle Eric Jutkowitz
Julie P.W. Bynum
Susan L. Mitchell
Noelle M. Cocoros
Oren Shapira
Kevin Haynes
Vinit P. Nair
Cheryl N. McMahill‐Walraven
Richard Platt
Ellen P. McCarthy
Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Medicare
Medicare Advantage
dementia, Alzheimer's disease
mild cognitive impairment
author_facet Eric Jutkowitz
Julie P.W. Bynum
Susan L. Mitchell
Noelle M. Cocoros
Oren Shapira
Kevin Haynes
Vinit P. Nair
Cheryl N. McMahill‐Walraven
Richard Platt
Ellen P. McCarthy
author_sort Eric Jutkowitz
title Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
title_short Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
title_full Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
title_fullStr Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
title_full_unstemmed Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
title_sort diagnosed prevalence of alzheimer's disease and related dementias in medicare advantage plans
publisher Wiley
series Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
issn 2352-8729
publishDate 2020-01-01
description Abstract Introduction One‐third of Medicare beneficiaries are enrolled in Medicare Advantage (MA). Yet, little is known about MA beneficiaries diagnosed with Alzheimer's disease (AD) and AD‐related dementias (AD/ADRD). Methods We calculated the prevalence of AD/ADRD diagnoses in 2014 and 2016 in three MA plans. We determined the demographic characteristics of beneficiaries diagnosed with AD/ADRD, and whether they disenrolled from the MA plan for any reason within 364 days from the index date. Results In 2014 and 2016, the overall prevalence of AD/ADRD diagnoses was 5.6% and 6.5%, respectively. In 2016, AD/ADRD beneficiaries were on average 82.4 (SD = 7.4) years of age, 61.8% female, and had multiple comorbidities. By 364 days post‐index date, 32% of beneficiaries with AD/ADRD had disenrolled from their plan. The demographic characteristics of 2014 beneficiaries with diagnosed AD/ADRD were similar to their 2016 counterparts. Discussion The prevalence of AD/ADRD diagnosis in MA is lower than rates reported in Medicare fee‐for‐service.
topic Medicare
Medicare Advantage
dementia, Alzheimer's disease
mild cognitive impairment
url https://doi.org/10.1002/dad2.12048
work_keys_str_mv AT ericjutkowitz diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans
AT juliepwbynum diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans
AT susanlmitchell diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans
AT noellemcocoros diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans
AT orenshapira diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans
AT kevinhaynes diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans
AT vinitpnair diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans
AT cherylnmcmahillwalraven diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans
AT richardplatt diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans
AT ellenpmccarthy diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans
_version_ 1721526274222981120